Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:7,10,13,16,19-Docosapentaenoic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000004 AN000004 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS nM
ST000916 AN001491 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS nM
ST000917 AN001497 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS nM
ST001289 AN002142 Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses Macrophages Mouse LIPID MAPS pmol/1E6 cells
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS pmol/mg
ST000005 AN000012 Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin Macrophages Mouse LIPID MAPS pmol/ug DNA
  logo